Weight training preserves muscle on GLP-1 drugs, study finds
New research shows that combining resistance exercise with GLP-1 receptor agonist treatment effectively prevents the muscle-mass loss that has been a concern with semaglutide-class obesity drugs.
- Participants doing resistance training lost negligible lean mass versus diet-only controls
- GLP-1 plus exercise preserved or slightly improved muscle strength metrics
- Findings may reshape prescribing guidance toward structured exercise recommendations